 |
FDA Approval Activities for this Drug
Refludan (lepirudin) Injection, 50mg/vial, Aventis Pharms NDA 20-807 Rufludan [lepirudin (rDNA)] Injection, Berlex , NDA 20-807/S-005
For the most up-to-date approval information, please locate this API using the drug index.
|